Back to results
US 2026/0035403 A1Published application
Nucleoside line-1 inhibitors
AssigneeTransposon Therapeutics, Inc.
InventorsEckard WEBER, Michael G. CORDINGLEY, Andrew James BURNIE, William BROWN, Chandra Mohan DARAPANENI, Marco PALADINO, Malay DOSHI, Jigneshkumar Jashbhai PATEL
Life of this patent
Estimating the term…
Abstract
The present disclosure provides LINE-1 inhibitors and methods of treating or preventing a disease, disorder, or condition in a subject in need thereof, the methods comprising administering to the subject a therapeutically effective amount of a LINE-1 inhibitor.
Claims21
1-23. (canceled)
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt or solvate thereof, or a tautomer thereof.
Dependencies are inferred from the claim text.